Date lodged: 30 November 2017
To ask the Scottish Government whether the Clinical Review of Cancer Waiting Times will look at whether brain and central nervous system cancers should be included in future reports that measure the performance of cancer waiting times, and what its position is on including these.
Answered by: Shona Robison 14 December 2017
The Clinical Review of Cancer Access Standards in Scotland provides an excellent opportunity to examine information on cancer waiting times that could significantly change and enhance the patient experience and will determine if any amendments or modifications are required to ensure the cancer waiting times standards best meet the needs of patients and the NHS for the future.
A wide range of views from stakeholders, patients and public have been gathered and draft recommendations are in development these include full evaluation of all (new and existing) tumour types in the Cancer Waiting Times dataset.